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Abstract
Background: Studies of sexuality or sexual behavior in childhood cancer survivors tend to
examine relationships or achievement of developmental milestones but not physiological
response to cancer or treatment. The purpose of this study is to (1) identify prevalence and risk
factors for sexual dysfunction in childhood cancer survivors, and (2) examine the extent to
which sexual dysfunction may be associated with health-related quality of life (HRQOL) and
psychosocial outcomes.
Methods: Five hundred ninety-nine survivors age 18–39 years completed standardized
measures of sexual functioning, HRQOL, psychological distress and life satisfaction.
Descriptive statistics assessed prevalence of sexual symptoms. Bivariate analyses identified
correlates of sexual symptoms and examined associations between symptoms and HRQOL/
psychosocial outcomes.
Results: Most survivors appear to be doing well, although 52% of female survivors and
32% of male survivors reported at least ‘a little of a problem’ in one or more areas of sexual
functioning. Mean symptom score for females was more than twice that of males. Sexual
symptoms were associated with reporting health problems. Significant associations between
sexual functioning and HRQOL outcomes were observed, with gender differences in strengths
of association suggesting that males find sexual symptoms more distressing than do females.
Conclusions: While most survivors appear to be doing well in this important life domain,
some young adult survivors report sexual concerns. While female survivors may report more
sexual symptoms than male survivors, males may experience more distress associated with
sexual difficulties. Better-specified measures of sexual function, behavior and outcomes are
needed for this young adult population.
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Medical illness has an adverse effect on sexual
health, most often due to physical symptoms or the
sequelae of treatment [1,2]. Schover [3] summarizes
the physiological impacts of cancer treatments on
adult sexuality in that cancer treatments may
damage one or more physiological systems needed
for a healthy sexual response, including hormonal,
vascular, neurologic and psychological elements of
sexual function. As a result of these impacts, sexual
dysfunction may be characterized by disturbances
in sexual desire and/or in the psycho-physiological
changes associated with the human sexual response
cycle [4].
The National Health and Social Life Survey
(NHSLS) conceptualizes sexual dysfunction as
symptoms or problems associated with (1) desire
for sex; (2) arousal difficulties (i.e. erection
problems in men, lubrication in women); (3)
inability to achieve climax or ejaculation; (4)
anxiety about sexual performance; (5) climaxing
or ejaculating too rapidly; (6) physical pain during
intercourse and (7) not finding sex pleasurable [5].
Large-scale population-based studies of sexual
health report prevalence of sexual dysfunction in
the general population at 10–52% for men and
25–63% for women [6,7]. The NHSLS (inclusive of
US adults age 18–59 years) suggests the prevalence
of sexual dysfunction at 43% of women and 31%
of men [5]. The NHSLS also found married men
and women to be at lower risk of experiencing
sexual symptoms when compared with non-
married counterparts. Age also was a strong
predictor of sexual difficulties, with younger
persons reporting fewer symptoms. Others have
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suggested that higher rates of sexual symptoms in
older adults are attributable to morbidities asso-
ciated with aging, and not with aging in and of
itself [2,8,9].
Although it is important to note what sexual
dysfunction is, it is equally important to recognize
that many people experience ‘dysfunction’ but are
not distressed. For example, women with anorgas-
mia who participated in a supportive care program
to increase orgasm reported that the program made
them more satisfied with their sex lives even though
their anorgasmia remained unchanged [10]. In a
study of non-distressed marriages many women
indicated that sexual satisfaction was not related to
desire, sexual activity frequency or number of
orgasms, but to closeness in relationship, sexual
attitudes and assertiveness [11]. In contrast, Ganz
[12] reported that young adults with cancer (not
young adult survivors of childhood cancer) experi-
ence greater distress as a result of sexual dysfunc-
tion or other reproductive effects associated with
treatment when compared with older adults. Thus,
it is important to examine sexual dysfunction to the
extent that it is associated with distress, life
satisfaction or health-related quality of life
(HRQOL).
Research on sexual functioning in adult cancer
patients and survivors is replete with studies
focusing on biophysiological response (see, for
example, Hollenbeck et al. [13]; Ganz et al. [14];
Miller et al. [15]), whereas studies of sexuality or
sexual functioning in childhood cancer survivors
tend to examine infertility or achievement of
psychosexual milestones. For example, childhood
cancer survivors experience delays in dating and
initiating social contacts [16,17], in marriage
[18–20] and in first time having sexual intercourse
[21–23]. They may be less likely than peers to be
sexually active and perhaps less satisfied with their
interpersonal relationships and sex life [23–26].
A recent Dutch study [17] of 60 childhood cancer
survivors indicated that half the sample reported
being seldom or never able to feel themselves
sexually attractive, felt almost no sexual attraction,
and seldom or never satisfied with their sexual lives.
Forty-one percent of the sample reported ‘sexual
problems’ and 18% reported negative effects of
their disease on their sexual life.
There appears to be a gap in the literature with
regard to physiological aspects of sexuality in
young adult survivors of childhood cancer. Appar-
ently there are no reports of the extent to which
cancer or treatment experienced as a child has any
affect on young adult survivors’ sexual interest,
ability to relax and enjoy sex, arousal or ability
to achieve orgasm. Furthermore, there appear to
be no reports of how sexual dysfunction may be
associated with psychosocial health status or
HRQOL. Indeed, a recent review of the state of
the science with regard to HRQOL in childhood
cancer survivors did not identify any studies
reporting on the potential role that sexual func-
tioning may play as it relates or contributes to
psychosocial function, well-being or HRQOL. [27].
Thus, the purpose of the study reported here is to
(1) identify prevalence and risk factors for sexual
dysfunction in young adult survivors of childhood
cancer, and (2) examine the extent to which sexual
dysfunction is associated with HRQOL, psycholo-
gical distress and life satisfaction.
Methods
Participants and procedures
A potential pool of 2864 respondents was derived
from electronic records maintained at two Southern
California institutions that treat pediatric oncology
patients and one mid-western United States chil-
dren’s hospital. Study eligibility criteria permitted
inclusion of survivors who were off treatment and
disease-free at the time of questionnaire comple-
tion, were between the ages of 18–39 years at time
of study, and 21 years of age or younger when
diagnosed with a malignancy. Potential subjects
were mailed survey questionnaires, informed con-
sent forms and a self-addressed stamped envelope.
Investigators maintained logs of when surveys were
mailed and returned. Subjects failing to return their
survey after 2 weeks were mailed a reminder letter.
After another 2 weeks, investigators mailed out a
second survey to non-respondents as a final
reminder. Unless the US postal service returned a
survey to marked ‘non-deliverable’, a subject who
did not return a survey was considered a non-
responder. All returned surveys were reviewed for
completeness. Missing data or items needing
clarification were noted and a staff research
assistant contacted subjects via US mail to obtain
missing data. Missing data (e.g. age, age at
diagnosis, cancer type) were supplemented by the
reviews of institutional records to the extent
possible. All protocols and questionnaires were
approved by the Institutional Review Boards of all
collaborating institutions.
Measures
The MOS Sexual Functioning [28] scale is a widely
used and validated instrument that identifies sexual
impairments and dysfunction associated with
serious health conditions or side effects of treat-
ments. The items focus on problems that respon-
dents perceive in their capacity to achieve sexual
arousal and orgasm. Four items for men and four
items for women are administered on an ordinal
scale ranging from 05 ‘not a problem’ to 4 5 ‘very
much a problem’. A fifth category permits respon-
dents to indicate ‘not applicable’, which is to be
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interpreted as an indication of not being sexually
active [29]. As per scoring instructions, the ‘not
applicable’ category is to be recoded as zero (‘not a
problem’) when scoring the measure. Summary
scores are calculated for men and women sepa-
rately by averaging items and then transforming
the scores to a 0–100 range scale. Higher scores
indicate more problems. Internal consistency relia-
bility (Cronbach’s alpha) in this sample was 0.90
for men and 0.90 for women.
HRQOL was assessed using the SF-36 [30], a
widely used and well-validated instrument that
assesses health status with regard to physical, social
and psychological functioning. Psychological dis-
tress was assessed by the 18-item Brief Symptom
Inventory (BSI-18) [31], an ordinal level scale
assessing the severity of symptoms indicative of
depression, anxiety and somatic distress. Life
satisfaction was assessed by the Ladder of Life
[32], a visual acuity scale ranging from 0–10 on
which respondents indicate their satisfaction with
life on a ‘ladder’ ranging from ‘worst possible life’
to ‘best possible life’ at three time points (past,
present, future).
Analyses
Descriptive statistics were calculated for demo-
graphic and cancer-related health status variables.
Means scores for the MOS Sexual Functioning
measure were compared among study participants
using general linear models adjusting for age at
study and age at diagnosis. Pearson product–
moment correlations were calculated to examine
bivariate associations among sexual functioning
scores and the SF-36 subscales, the BSI-subscales,
the Ladder of Life scores, age at study and age at
diagnosis. SPSS version 15.0 was used for analyses.
Results
From 2864 mailed surveys, the US postal service
returned 576 (20.3%) unopened surveys, indicating
they were undeliverable. An additional 22 returned
surveys were marked ‘deceased’. Among 2266
assumedly live subjects for whom surveys were
not returned by the postal service, 666 (29.3%)
consented to participate and completed a self-
report questionnaire. The remaining 1600 subjects
were deemed ‘non-respondents’. Of the 666
respondents, 39 were eliminated from subsequent
analyses due to surveys being completed by
individuals who in fact did not fit eligibility criteria
with regard to age at study (18–39 years old), age at
diagnosis (21 years or younger) or treatment status
(not currently receiving treatment), or because
the questionnaire was completed by a surrogate.
An additional 28 respondents did not complete
portions of the survey necessary to examine the
variables of interest for this analysis. Thus, the
analyses reported here are based on responses from
the 599 participants.
A comparison of these respondents to non-
respondents showed that respondents were signifi-
cantly more likely to be female (po0.000) (Table 1).
Respondents and non-respondents also differed
significantly in terms of cancer diagnoses, with a
larger than expected proportion of leukemia
survivors and smaller than expected proportion of
brain tumor survivors comprising the respon-
dent group (po0.001). No statistically significant
differences were observed with regard to age
at study, age at diagnosis or years since diag-
nosis. Sample characteristics are summarized in
Table 1.
Sexual functioning
Frequencies for individual items are summarized in
Table 2. Missing data for any given item was no
more than 5%. For any given symptom, most
survivors reported an absence of sexual problems.
Fifty-two percent of females and 32% of males
reported at least ‘a little of a problem’ in one or
more areas of their sexual functioning. Overall,
42.7% of the entire sample endorsed at least one
problematic symptom.
Overall mean symptom score (transformed) for
females (21.6) was more than twice that of males
(10.6) (Table 3). No statistically significant differ-
ences in sexual functioning were observed across
education, race or type of cancer. Male survivors
with incomes of less than $25 000 reported sig-
nificantly higher symptom scores than did males
earning more than $25 000. Scores for men and
women reporting health problems were signifi-
cantly greater than for those reporting no health
problems. Married female survivors reported sig-
nificantly greater sexual dysfunction than did non-
married female survivors, whereas no significant
differences (at po0.05) were seen for males. Age at
study and age at diagnosis were associated with
reporting symptoms, with symptom scores increas-
ing among older survivors and those diagnosed at
older ages (Table 4).
Life satisfaction
Statistically significant correlations between sexual
dysfunction and life satisfaction were observed for
both male and females. Current and past life
satisfaction increased significantly as survivors
reported less sexual dysfunction (Table 4). Only
for males was future life satisfaction associated
with sexual functioning in that an anticipated
better life in the future was associated with less
sexual dysfunction.
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Distress
Sexual functioning was significantly correlated with
all subscale and global measures of distress for
both males and females (Table 4). Those reporting
more dysfunction also reported greater depressive
symptoms, somatization and anxiety, as well as a
greater overall symptom index score.
HRQOL
Both males and females reported significant
negative associations between sexual dysfunction
and six of the eight subscales comprising the SF-36
(Table 4). HRQOL with regard to bodily pain,
general health, vitality, social functioning, role-
emotional status and mental health was worse
among those reporting greater sexual dysfunction.
Greater sexual dysfunction also was significantly
associated with lower role function-physical for
females. In examining the two component scores of
the SF-36, sexual dysfunction was significantly
associated with worse mental health functioning
(MCS) for both men and women. Sexual dysfunc-
tion was significantly associated with worse physi-
cal functioning (PCS) for females only. Overall, the
strength of association for sexual symptoms and all
HRQOL, life satisfaction and distress measures
was greater for males than for females (Table 4).
Discussion
This manuscript reports the prevalence of sexual
dysfunction in a moderately large sample of young
adult survivors of childhood cancer. While most
survivors appear to be doing well in this important
life domain, some young adult survivors report
sexual concerns. For some, sexual dysfunction
appears associated with detriments in psychologi-
cal health and quality of life.
The proportion of respondents reporting at least
‘a little bit of a problem’ (43%) is roughly
comparable to the 41% of childhood cancer
survivors indicating ‘sexual problems’ in the child-
hood cancer survivor study by van Dijk et al. [17].
In addition, a comparison of findings here to
results from the NHSLS is informative when
considered in the context of the difference in age
ranges for these studies. For example, the NHSLS
is inclusive of US adults age 18–59 years, whereas
the age range for survivors in this study was 18–39.
Using Sherbourne’s [28] algorithm for determining
sexual dysfunction, in which any response other
than ‘not at all’ suggests some level of dysfunction,
the proportion of young adult survivors of child-
hood cancer demonstrating sexual dysfunction in
this study (53% for females; 31% for males)
exceeds the 43% of women and 32% of men
reported in the NHSLS [5]. Given that the rates of
sexual dysfunction increase with age in the general
population [2,5,33], one could argue that the
proportion of those reporting sexual dysfunction
in this younger childhood cancer survivor cohort
should in fact be less than the proportions reported
in the NHSLS. As it is not, and in the absence of





dents n 5 1600
Freq (%) Freq (%)
Gender
Female 316 (52.8) 612 (39.8)
Male 282 (47.2) 927 (60.2)
Race/ethnicity






Unemployeda 73 (12.5) NA
Employed/occupiedb 510 (87.5)
Education
HS Grad or less 115 (19.7) NA
Some college 270 (46.2)
4-year college grad 199 (34.1)
Marital status
No 318 (54.0) NA
Yes 271 (46.0)
Income




Leukemia 225 (37.7) 173 (21.1)
Hodgkins’ disease 98 (16.4) 121 (14.8)
Non-Hodgkin’s Lymphoma 54 (9.0) 74 (9.0)
CNS/Brain Tumor 79 (13.2) 191 (23.3)
Solid tumors/soft tissue tumors 73 (12.2) 74 (9.0)
Kidney (e.g. Wilm’s) 25 (4.2) 34 (4.2)
Otherc 43 (7.2) 152 (18.6)
Reports current health problems (other
than cancer related )
No 267 (45.7) NA
Yes 317 (54.3)
Age at study, in years
Mean (SD) 27.0 (5.5) 26.5 (5.5)
Range: 18–39
Age at diagnosis, in years
Mean (SD) 11.0 (6.0) 10.8 (6.1)
Range: 0–21
Years since diagnosis
Mean (SD) 16.0 (7.0) 15.7 (6.9)
Range: 2–37
NA 5 not available from participating institutions; frequencies do not always add
up to 599 for survivors or 1600 for non-respondents due to missing data.
Indicates statistically significant differences at po0.05;  po0.01; po0.001.
aincludes those ‘on leave/disability’, ‘unemployed’ or ‘permanently unable to
work’.
bincludes ‘full-time employment’, ‘part-time employment’, ‘student’, or ‘home-
maker’.
cIncludes germ cell tumors, retinoblastoma, neuroblastoma and other tumors not
specified.
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normative population data on sexual dysfunction
in adolescents and young adults, these findings
suggest that childhood cancer survivors may be at
increased risk for sexual dysfunction. It is possible,
however, that these differences across studies are
confounded by the use of different instruments to
assess sexual problems.
Gender differences
Female survivors appear to be far more signifi-
cantly affected in their sexual functioning than are
male survivors, with a symptom score being
twice that of males. Furthermore, much larger
proportions of females (12%–19% per item)
compared with males (6%–12% per item) endorsed
the ‘not applicable’ response, suggesting less
involvement in sexual activity. These findings in
and of themselves do not necessarily mean that
women’s sexual lives are more problematic than
those of men. Theory and research in sexuality
distinguishes two different physiologic and cogni-
tive processes underlying men’s and women’s
sexual attitudes and behavior. Women tend to
operate within a cognitive framework of ‘Am I
desirable’, whereas men operate from a vantage
point of ‘What do I desire?’ [34] Research on
gender differences in patterns of genital sexual
Table 2. Descriptive statistics for MOS sexual functioning scale
Frequency (%) of item response
Not a problem A little of a problem Somewhat of a problem Very much a problem
Men
Lack of sexual interest 219 (79.9) 28 (10.2) 15 (5.5) 12 (4.4)
Unable to relax and enjoy sex 218 (79.9) 24 (8.8) 24 (8.8) 7 (2.6)
Difficulty in becoming sexually aroused 232 (84.7) 22 (8.0) 12 (4.4) 8 (2.9)
Difficulty getting or keeping an erection 218 (79.6) 33 (12.1) 8 (2.9) 15 (5.5)
Women
Lack of sexual interest 190 (62.7) 54 (17.8) 31 (10.2) 28 (9.2)
Unable to relax and enjoy sex 197 (65.2) 47 (15.6) 34 (11.3) 24 (7.9)
Difficulty in becoming sexually aroused 199 (65.9) 52 (17.2) 30 (9.9) 21 (6.6)
Difficulty in having an orgasm 182 (60.5) 44 (14.6) 41 (13.6) 34 (11.3)
Table 3. Sexual dysfunction scores by select sociodemographic and medical characteristics; means and standard errors adjusted for
age at study and age at diagnosis
Females Males
Mean (se) F (p-value) Mean (se) F (p-value)
Overall 21.6 (28.6) 10.6 (21.6)
Race/ethnicity
White 22.7 (2.0) 0.67 11.8 (1.6) 1.15
Non-White 19.8 (2.9) (0.41) 8.9 (2.2) (0.29)
Education
HS Grad or less 20.4 (4.6) 0.05 10.6 (2.6) 0.20
Some college 22.1 (2.4) (0.95) 10.0 (2.0) (0.82)
4-year college grad 21.9 (2.7) 12.1 (2.6)
Marital status
No 17.7 (2.3) 6.48 12.9 (1.8) 3.10
Yes 26.1 (2.3) (0.01) 8.0 (2.0) (0.08)
Income
o$25K 25.4 (2.8) 2.00 15.2 (2.3) 5.8
4$25K 20.4 (2.1) (0.16) 8.5 (1.6) (.02)
Cancer Type
Leukemia 19.4 (2.8) 0.60 12.4 (2.1) 0.97
Hodgkin’s disease 22.7 (4.1) (0.73) 4.4 (3.3) (.45)
NHL 31.6 (6.6) 11.7 (3.9)
CNS/brain tumor 20.1 (4.7) 9.1 (3.8)
Solid tumors/soft tissue tumors 24.6 (4.5) 12.0 (4.0)
Kidney tumor (Wilm’s) 18.2 (7.2) 6.3 (9.7)
Other 23.4 (6.6) 15.5 (4.7)
Reports health problems
No 13.4 (2.5) 19.0 6.9 (1.8) 8.52
Yes 27.9 (2.1) (0.000) 14.6 (1.9) (0.004)
F-statistic derived from general linear models, adjusted for age at study and age at diagnosis.
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arousal suggest that physiological arousal for
women, as measured by lubrication and swelling,
is not associated (statistically correlated) with their
subjective experience of feeling sexually aroused
[35]. In contrast, men experience a strong positive
correlation between subjective sexual arousal and
physiological response. The meaning and signifi-
cance of this difference is that sexual arousal in
women is manifested as a psychological experience
inclusive of awareness of both desire and being
desired, and is not directly correlated with the
physiological response of genital swelling and
lubrication. It may be that cultural expectations
for females to contextualize experience, along with
the physiological differences in anatomic struc-
tures—literally that males can see their arousal and
females cannot—form the basis for different
experiences of desire and arousal. Thus, if female
cancer survivors are not dating or in a serious
intimate relationship then they are potentially less
likely to be aware of desire and arousal since they
are less likely to be engaging in sexual activity and
intercourse. In the general population even mas-
turbation begins at a later point in development for
females than for males, in that women typically
masturbate after they have reached their late teens/
early twenties and usually after they have begun a
sexual relationship [36].
Another reason why there might be twice the
number of females indicating sexual symptoms as
compared with males may be the potentially
traumatizing nature of cancer treatment. Indeed,
post-traumatic stress symptoms have been reported
in both male and female children treated for
childhood cancers [37,38], and female survivors
have been identified as being at significantly greater
risk for experiencing post-traumatic stress [39]. It
may be that young women are more likely than
young men to experience cancer-related physical
changes, medical procedures and treatment as
traumatic assaults impacting their physical being,
psychosexual development and heightened aware-
ness about body and body image. Given that
research and theory on childhood development
suggest that females are more vulnerable to being
traumatized by abuse than are males [40–42],
gender differences in sexual dysfunction may be
attributable to how males and females differ in
their experiences of cancer as traumatic or abusive.
The differential impact of sexual dysfunction
among male and female childhood cancer survivors
may indeed be related to post-traumatic stress
symptoms.
The gender differences in the associations be-
tween life satisfaction and HRQOL observed here
are notable and further distinguish males from
females with regard to the role that sex plays in
their lives. The significant statistical relationship
between sexual symptoms and lower life satisfac-
tion in the future for males only suggests that males
anticipate sex to be an important component of
future life satisfaction, whereas females do not, or
at least to a much lesser extent. With regard to
HRQOL, sexual dysfunction was associated with
physical limitations interfering with daily lives and
overall physical functioning (as indicated by the
Physical Component Score of the SF-36) only for
women. For men, regardless of their physical
health or functioning, their sexual capabilities and
desires do not appear affected. In contrast, an
examination of the magnitude of the correlation
coefficients among the SF-36 subscale scores and
sexual symptoms scores suggests that for men,
mental health functioning appears more salient as it
relates to reporting sexual symptoms, as sexual
symptoms was correlated with the Mental Health
Component Score of the SF-36 at r50.43 for
males as compared with r50.24 for females.
Overall, the gender differences in strengths of
association observed between sexual symptoms
and all HRQOL and distress measures suggest
that male survivors report greater distress asso-
ciated with sexual symptoms than do female
survivors.
Other factors associated with sexual problems
The correlation coefficients reported here suggest
that decrements in HRQOL and psychological
well-being may be partially attributable to sexual
problems, and perhaps that sexual problems are
exacerbated by limitations in physical functioning




Age at Dx 0.163 0.140
Age at study 0.228 0.134
Life satisfaction
Now 0.362 0.209
In the past 0.139 0.142
In the future 0.384 0.110
Distress
Depressive symptoms 0.433 0.291
Somatization 0.335 0.233
Anxiety 0.408 0.285
Global Index Score 0.430 0.311
HRQOL
Physical function 0.076 0.107
Role-physical 0.080 0.196
Bodily pain 0.179 0.122
General health 0.285 0.261
Vitality 0.369 0.248
Social functioning 0.386 0.225
Role-emotional 0.349 0.213
Mental health 0.407 0.201
Physical Component Score 0.039 0.157
Mental Component Score 0.425 0.243
pr0.05; pr0.01.
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and mental health status. Data suggested that
respondents reporting health problems were sig-
nificantly more likely to report sexual problems.
Although a direction of causation cannot be
determined at this time, due to the limits of a
cross-sectional research design, it seems evident
that sexual health plays an important role in the
constellation of HRQOL in this population.
Furthermore, given that the reporting of sexual
symptoms appeared to increase with age at
diagnosis, it is possible that treatment occurring
during puberty may contribute negatively to
physical and/or psychological development, thus
having ramifications for sexual attitudes, behaviors
and experiences.
Although no significant differences in sexual
function scores were observed across cancer type,
the scoring procedure obscures an important
observation in that male survivors of brain tumors
were 1.5–3.0 times more likely than male survivors
of hematological cancers and solid tumors to leave
an item response blank or else endorse the response
category ‘not applicable’. For example, 34.4% of
male brain tumor survivors, compared with 10.2%
of male hematological survivors and 12.3% of male
solid tumor survivors, endorsed ‘not applicable’ for
the item ‘Unable to relax and enjoy sex’. Propor-
tions of female brain tumor survivors endorsing
‘not applicable’ also were greater when compared
with female survivors of other cancer types, but
nowhere near the two- to three-fold increases
observed for male brain tumor survivors. One
may assume that missing data or an endorsement
of ‘not applicable’ serves as an indication for not
being sexually active. This is Stewart and Ware’s
[29] justification for why this response is recoded as
0 for ‘not a problem’. Thus, the findings here
suggest that male brain tumor survivors are less
likely than male survivors of other pediatric
malignancies to be sexually active, which would
be consistent with studies suggesting excess debil-
itation in social involvement and integration for
brain tumor survivors [43,44]. In contrast, female
survivors’ level of sexual activity (as inferred by
endorsement of ‘not applicable’) across all cancer
diagnostic categories included here was relatively
the same.
With research indicating delays in childhood
survivors’ involvement in dating, intimate relation-
ships and sexual behavior, these young adults are
at risk for not learning or adopting healthy sexual
behaviors. This may explain why, in contrast to
studies of sexual functioning in the general
population, married female cancer survivors were
more, not less, likely to report sexual symptoms. It
is possible that the delays in both dating and
development of sexually intimate relationships
resulted in females having even less knowledge of
their psychosexual functioning and thus creating
more sexual concerns that these female survivors
then carry forth into their marriages or committed
relationships. Simultaneously, if women are not
dating, they are potentially not likely to be
bothered or distressed as much by their lack of
desire or inability to become sexually aroused, even
if they have indicated within the context of a survey
instrument that these sexual functions are proble-
matic, since women tend to associate desire and
arousal with partnered activity. Thus, it is im-
portant to interpret findings from studies of sexual
functioning cautiously, and to examine the findings
as they relate to other critical biopsychosocial
outcomes and in the context of psychosexual
development. Indeed, there could be many expla-
nations alone or in combination as to why women
may be experiencing more sexual problems, includ-
ing low hormonal levels, self-image being more
challenging for women who are disfigured or
disabled by illness/treatment, infertility in the
context of womanhood or lack of support from
intimate partners.
Study limitations
The opportunity to make meaningful and clinically
relevant comparisons of sexual function in these
childhood cancer survivors to others is limited by a
lack of reported empirical data derived from
similarly aged samples using similar instrumenta-
tion. The algorithms used to determine sexual
dysfunction in the MOS Sexual Functioning
instrument and in the NHSLS are not only
different but also represent liberal, and perhaps
problematic, criteria for determining prevalence of
sexual dysfunction, possibly suggesting problems
when none exist [45,46]. Yet, the NHSLS stands as
an oft-cited study used to emphasize proportions of
the US population reporting sexual dysfunction
[46]. In addition, extant research suggests that
long-term effects of cancer treatment, including
infertility and deleterious reproductive effects, are
attributable to intensive treatment exposures [47].
Unfortunately, a lack of resources and inability to
mine institutional records for objective health
status details limited the ability to investigate this
important relationship. Restricted to self-reported
measures of perceived health status, this study at
least uncovered the expected result that differences
in reporting sexual problems would be partially a
function of current health problems.
Finally, the relatively small response rate (29%)
reflects the limitations of conducting retrospective
studies of a young adult survivor population many
years beyond their cancer experience and limits the
generalizability of these findings. However, while
small, the reported response rate is most likely an
underestimation of the true response rate. First,
assuming a 15% mortality rate (85% survival rate)
for off-treatment survivors of childhood cancer
[48], one could estimate that approximately 324
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individuals among the 2166 assumedly alive sub-
jects would be deceased; however, we were only
able to confirm 22 deceased patients. Decreasing
the denominator by 324 persons theoretically
improves the overall response rate to 36.2%.
Secondly, although investigators provided partici-
pating institutions with eligibility parameters to
produce an eligible sample pool, institutional
restrictions and lack of available resources prohib-
ited investigators from reviewing institutional
records and actually confirming that all 2864
patients included in the potential sample pool in
fact fit eligibility criteria. As self-report data from
completed and returned surveys indicated that
some respondents were too old for the study or
too old at time of diagnosis, we can presume that
some unknown percentage of non-respondents also
did not fit eligibility criteria, thereby further
reducing the denominator and improving the
response rate. Obviously, the low response rate
may suggest a response bias and limits the ability to
generalize to a population of young adult survivors
of childhood cancer. However, the findings
reported here have utility in that no studies of
sexual functioning in childhood cancer survivors
have been reported, and these data may serve as a
starting point by which to further examine sexual
functioning in this population.
Implications for practice and research
More research is needed to identify possible
contributors to sexual difficulties. The social life
disruptions and emotional upheavals experienced
by many cancer survivors may manifest as sexual
dysfunction. Alternatively, or perhaps additionally,
sexual difficulties in long-term survivors of child-
hood cancer may have a biological or organic basis
that has as yet gone undetected or unreported. The
long-term endocrine system changes or imbalances
experienced by childhood survivors may be im-
plicated in this regard, perhaps having direct
impacts on libido, arousal or lubrication.
Better-specified measures of sexual function,
behavior and outcomes are needed for this young
adult population. We recognize the limitations of
the MOS Sexual Functioning measure adminis-
tered to this population of young people in that
participants were not asked directly if they were
sexually active. As a result, the scoring procedures,
which assume and recode a response of ‘not
applicable’ to mean ‘not a problem’, obscures the
specificity of the challenges that some childhood
cancer survivors may be having with regard to
sexual function, behavior and intimacy. Compre-
hensive assessments of sexual outcomes need to
evaluate physical function along with the extent to
which functional ‘limitations’ are experienced as
problematic or distressing. They also should
distinguish issues related to sexuality from issues
related to infertility. Finally, future research needs
to determine how sexual symptom prevalence and
experiences compare with same-age peers and
gender-matched controls; and, multivariate statis-
tical analytic models are needed to examine the
multiple pathways by which sexual dysfunction,
physical and mental health status, psychological
distress and quality of life are interrelated.
With regard to clinical care, there is a need to
provide sexual health assessment in survivor
clinical visits that includes attention to functioning
and the psychological components of health and
well-being, including self-image, subjective attitude
toward one’s own sexuality and relationships with
intimate partners. Clinicians must be skillful in
their approach and informed of the developmental
and psychosocial needs unique to young adults in
general, and particularly among young adults with
cancer [49]. Administration of screening tools, as
well as clinical assessments and other therapeutic
endeavors, must be geared toward making these
young people comfortable discussing personal
issues and providing referral for additional coun-
seling when indicated. Psycho-educational pro-
grams and counseling that is age-appropriate
and addresses sexual development and function
explicitly have the potential to enhance patient–
provider communication around these issues.
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